期刊文献+

Research Progress of Continuous Blood Purification in the Treatment of Severe Sepsis in Children 被引量:1

下载PDF
导出
摘要 Pediatric sepsis is the most common disease in pediatric critical illness,because the main reason for the disease is that children's immune level is not high or the immune system is not perfect,when children's lung,abdominal cavity and blood system are infected,it will cause systemic inflammation and immune dysfunction.Early clinical symptoms are mainly irregular and intermittent fever.When the disease develops to severe sepsis,the children will suffer from acute heart failure,oliguria,respiratory alkalosis and even multiple organ failure.The incidence of death is high.It is reported that the incidence rate of sepsis in children can reach 0.3%,and the mortality rate is 50%.High incidence rate,high mortality rate and high treatment cost are the biggest problems in the pediatric field.In the past,the clinical hope of clearing away heat and toxin,promoting blood circulation and removing stasis,strengthening inflammation and other methods in traditional Chinese medicine,but the treatment effect is not ideal.With the improvement of modem medical understanding of sepsis,continuous blood purification therapy is introduced into the treatment of children with severe sepsis.In order to further explore the effect of continuous blood purification in the treatment of children with severe sepsis,the author summarizes the clinical practice experience and relevant literature,hoping to provide reference for relevant medical staff。
出处 《Journal of Clinical and Nursing Research》 2021年第3期58-61,共4页 临床护理研究(英文)
  • 相关文献

参考文献6

二级参考文献54

  • 1Dellinger RP,Levy MM,Rhodes A,et al.Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock:2012[J].Crit Care Med,2013,41 (2):580-637.
  • 2Hirasawa H.Indications for blood purification in critical care[J].Contrib Nephrol,2010,166:21-30.
  • 3Servillo G,Vargas M,Pastore A,et al.Immunomodulatory effect of continuous venovenous hemofiltration during sepsis:preliminary data[J/OL].http://www.hindawi.com/journals/bmri/2013/108951.
  • 4Zhang H,Wang HY,Bassel-Duby R,et al.Role ofinterleukin-6 in cardiac inflammation and dysfunction after burn complicated by sepsis[J].Am J Physiol Heart Cire Physiol,2007,292 (5):H2408-H2416.
  • 5Pathan N,Hemingway CA,Alizadeh AA,et al.Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock[J].Lancet,2004,363 (944):203-209.
  • 6Carlson DL,Willis MS,White DJ,et al.Tumor necrosis factor-alpha-induced caspase activation mediates endotoxin-related cardiac dysfunction[J].Crit Care Med,2005,33 (5):1021-1028.
  • 7Ronco C,Tetta C,Mariano F,et al.Interpreting the mechanisms of continuous renal replacement therapy in sepsis:the peak concentration hypothesis[J].Artif Organs,2003,27 (9):792-801.
  • 8Cusack RJ,Rhodes A,Lochhead P,et al.The strong ion gap does not have prognostic value in critically ill patients in a mixed medical/surgical adult ICU[J].Intensive Care Med,2002,28 (7):864-869.
  • 9Cole L,Bellomo R,Journois D,et al.High-volume haemofiltration in human septic shock[J].Intensive Care Med,2001,27 (6):978-986.
  • 10Chon GR,Chang JW,Huh JW,et al.A comparison of the time from sepsis to inception of continuous renal replacement therapy versus RIFLE criteria in patients with septic acute kidney injury[J].Shock,2012,38 (1):30-36.

共引文献55

同被引文献21

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部